• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Changes in cerebrospinal fluid levels of malondialdehyde and glutathione reductase activity in multiple sclerosis.

作者信息

Calabrese V, Raffaele R, Cosentino E, Rizza V

机构信息

Institute of Biochemistry, University of Catania School of Medicine, Italy.

出版信息

Int J Clin Pharmacol Res. 1994;14(4):119-23.

PMID:7607784
Abstract

The chemical composition of human cerebrospinal fluid (CSF) is considered to reflect brain metabolism. In this study we measured malondialdehyde (MDA) levels and the activity of enzymes involved in antioxidative processes, glutathione reductase and glutathione peroxidase, in human cerebrospinal fluid of multiple-sclerosis (MS) patients and normal healthy volunteers. Our results indicated that the cerebrospinal fluid in MS showed significantly higher endogenous levels of MDA than the control, as well as a much greater resistance to in-vitro stimulation test. In addition, we found the activity of GSH reductase significantly increased, about twice the control values, whereas the activity of glutathione peroxidase was markedly decreased as compared to control values. Our findings suggest that in MS the activity of antioxidant enzymes is modified, and indicates the conceivable possibility of a pathogenic role of oxidative stress in the determinism of the disease.

摘要

相似文献

1
Changes in cerebrospinal fluid levels of malondialdehyde and glutathione reductase activity in multiple sclerosis.
Int J Clin Pharmacol Res. 1994;14(4):119-23.
2
Serum and cerebrospinal fluid antioxidant activity and lipid peroxidation in Guillain-Barre syndrome and multiple sclerosis patients.格林-巴利综合征和多发性硬化症患者血清和脑脊液中的抗氧化活性和脂质过氧化作用。
Int J Neurosci. 2010 Apr;120(4):301-4. doi: 10.3109/00207451003695690.
3
[Decreased antioxidant-defence mechanisms in cerebrospinal fluid (CSF) in patients with tick-borne encephalitis (TBE)].[蜱传脑炎(TBE)患者脑脊液(CSF)中抗氧化防御机制降低]
Neurol Neurochir Pol. 2002 Jul-Aug;36(4):767-76.
4
[Evaluation of oxidoreductive potential of patients with neuroborreliosis].[神经莱姆病患者氧化还原电位的评估]
Przegl Epidemiol. 2002;56(3):425-33.
5
Oxidative stress in perinatal asphyxia.围产期窒息中的氧化应激
Pediatr Neurol. 2008 Mar;38(3):181-5. doi: 10.1016/j.pediatrneurol.2007.10.008.
6
Malondialdehyde, glutathione, glutathione peroxidase and homocysteine levels in type 2 diabetic patients with and without microalbuminuria.2型糖尿病伴和不伴微量白蛋白尿患者的丙二醛、谷胱甘肽、谷胱甘肽过氧化物酶和同型半胱氨酸水平。
Ann Clin Biochem. 2005 Mar;42(Pt 2):99-104. doi: 10.1258/0004563053492838.
7
Antioxidant enzymes and melatonin levels in patients with bronchial asthma and chronic obstructive pulmonary disease during stable and exacerbation periods.支气管哮喘和慢性阻塞性肺疾病患者在稳定期和加重期的抗氧化酶和褪黑素水平。
Cell Biochem Funct. 2009 Jul;27(5):276-83. doi: 10.1002/cbf.1569.
8
Antioxidative enzymes activity and malondialdehyde concentration during mitoxantrone therapy in multiple sclerosis patients.在多发性硬化症患者的米托蒽醌治疗期间抗氧化酶活性和丙二醛浓度的变化。
J Physiol Pharmacol. 2012 Dec;63(6):683-90.
9
Oxidative stress indicators are elevated in de novo Parkinson's disease patients.氧化应激指标在新发帕金森病患者中升高。
Funct Neurol. 1999 Jul-Sep;14(3):141-7.
10
Oxidative stress and enzymatic antioxidant status in patients with nonalcoholic steatohepatitis.非酒精性脂肪性肝炎患者的氧化应激与酶促抗氧化状态
Ann Clin Lab Sci. 2004 Winter;34(1):57-62.

引用本文的文献

1
The impact of oxidative stress on symptoms associated with multiple sclerosis.氧化应激对多发性硬化相关症状的影响。
Sci Rep. 2025 Jul 2;15(1):22983. doi: 10.1038/s41598-025-07429-0.
2
Carboxymethyllysine and carboxyethyllysine in multiple sclerosis patients.多发性硬化症患者体内的羧甲基赖氨酸和羧乙基赖氨酸
Arch Med Sci. 2020 May 27;20(3):736-742. doi: 10.5114/aoms.2020.95654. eCollection 2024.
3
Oxidative Stress Markers in Multiple Sclerosis.多发性硬化症中的氧化应激标志物。
Int J Mol Sci. 2024 Jun 7;25(12):6289. doi: 10.3390/ijms25126289.
4
Ferroptosis induces detrimental effects in chronic EAE and its implications for progressive MS.铁死亡导致慢性 EAE 产生有害影响及其对进行性 MS 的影响。
Acta Neuropathol Commun. 2023 Jul 25;11(1):121. doi: 10.1186/s40478-023-01617-7.
5
Overview of the Neuroprotective Effects of the MAO-Inhibiting Antidepressant Phenelzine.单胺氧化酶抑制型抗抑郁药苯乙肼的神经保护作用概述。
Cell Mol Neurobiol. 2022 Jan;42(1):225-242. doi: 10.1007/s10571-021-01078-3. Epub 2021 Apr 10.
6
Monitoring the Redox Status in Multiple Sclerosis.监测多发性硬化症中的氧化还原状态。
Biomedicines. 2020 Oct 12;8(10):406. doi: 10.3390/biomedicines8100406.
7
The role of glial-neuronal metabolic cooperation in modulating progression of multiple sclerosis and neuropathic pain.胶质神经元代谢合作在调节多发性硬化症和神经病理性疼痛进展中的作用。
Immunotherapy. 2019 Feb;11(2):129-147. doi: 10.2217/imt-2018-0153.
8
Metabolomic profiling of CSF in multiple sclerosis and neuromyelitis optica spectrum disorder by nuclear magnetic resonance.通过核磁共振对多发性硬化症和视神经脊髓炎谱系障碍患者脑脊液进行代谢组学分析。
PLoS One. 2017 Jul 26;12(7):e0181758. doi: 10.1371/journal.pone.0181758. eCollection 2017.
9
In vivo evidence of oxidative stress in brains of patients with progressive multiple sclerosis.体内氧化应激在进展性多发性硬化症患者大脑中的证据。
Mult Scler. 2018 Jul;24(8):1029-1038. doi: 10.1177/1352458517711568. Epub 2017 Jun 1.
10
Redox Events As Modulators of Pathology and Therapy of Neuroinflammatory Diseases.氧化还原事件作为神经炎症性疾病病理和治疗的调节因子
Front Cell Dev Biol. 2016 Jun 23;4:63. doi: 10.3389/fcell.2016.00063. eCollection 2016.